October 22
Yichang Renfu Pharmaceutical Co., Ltd.
(hereinafter referred to as "Yichang Renfu ")
held a national listing conference for domestic clobazhan
Yichang Renfu President Du Wentao
Yichang Renfu President Du Wentaointroduced
This domestically produced clobazhan tablets
specification is 10mg/piece, 28 pieces per box
priced at 84 yuan per box
"is the lowest price in the world"
"As a parent of a child with epilepsy, after the policy of importing clobazhan was implemented, I was extremely excited to hear that domestic clobazhan tablets were also launched one after another. Our children's families can finally legally use clobazhan, and there is no need to worry about not being able to buy medicine."
Rare epilepsy disease group owner and patient Min Wen said that looking back at the entire process of clobazhan's listing, "a mixed feelings are mixed. Our problem was finally solved successfully, which is inseparable from the unremitting efforts of all parties from the country to the society."
Lobazhan Tablets
belongs to the second category of psychocontrol drug
3 has not been approved for the market for sale in China for a long time
According to previous reports, Lobazhan is a broad-spectrum anti-epileptic seizure drug for the treatment of rare epilepsy diseases, and has been used as an anti-epileptic drug in more than 100 countries.
But Lobazan belongs to
Class 2 psychocontrol drugs
has not been approved for marketing in China for a long time
Family members of children can only go abroad from
Purchase the formally listed Lobazhan
September 22 this year
Good news finally came
Lobazhan can finally buy
Temporary imported Lobazhan
National first prescription prescribed in Beijing Union Hospital
Domestic clobazhan is listed on
Anti-epileptic Important milestone in the development of the epilepsy industry
On October 22, Hong Zhen, president of the China Anti-epilepsy Association, said at the national market launch conference for domestic clobazhan that many relevant parties cooperated to quickly respond to and use the rapid launch of domestic clobazhan to completely solve the drug outage crisis. This is an important milestone in the development of my country's anti-epilepsy industry.
domestically produced clobazhan was officially launched
Du Wentao introduced that in 2017, Yichang Renfu paid attention to clobazhan in the "Second Batch List of Recommendations for Drugs for Encouraging R&D Application for Children" released by the former National Health and Family Planning Commission and other institutions, and decided to apply for clobazhan project; last year, after the shortage of clobazhan drugs appeared, in order to solve the urgent drug demand of rare disease group as soon as possible, the company increased its personnel and resources investment. Finally, in September this year, the clobazhan tablets produced by the company were approved for listing.
"In order to better serve the clinical practice and ensure the accessibility of drugs, the domestically produced clobazan tablets produced by Yichang Renfu are priced at 84 yuan per box. I hope everyone sees our sincerity and hopes that this price meets everyone's expectations." Du Wentao said.
Du Wentao also said that after the drug is launched, the company will continue to carry out drug-related clinical research; at the same time, by participating in and organizing relevant academic conferences in the field of epilepsy, it can accurately convey drug-related information and treatment knowledge to ensure patients' reasonable and safe use of clobazan.
In addition
appeals to parents of children
The company is preparing to launch
Lobazhan tablets into
l0 Application for the National Medical Insurance Directory
In the later stage,
Cooperation between third-party public welfare funds
Provides drug assistance for patients in families with financial difficulties
- END ——
Manuscript source | Red Star News Pengpai News
年彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩彩
